Should We Be Prescribing Stimulants to Patients With Multiple Sclerosis?: A Case Report of Stimulant-Associated Psychosis

J Clin Psychopharmacol. 2023 Nov-Dec;43(6):551-553. doi: 10.1097/JCP.0000000000001766. Epub 2023 Sep 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Central Nervous System Stimulants* / adverse effects
  • Humans
  • Multiple Sclerosis* / drug therapy
  • Psychotic Disorders* / drug therapy

Substances

  • Central Nervous System Stimulants